Sun Pharmaceutical Industries Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018
SUNPHARMA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Sun Pharmaceutical Industries has submitted a routine compliance certificate to the stock exchanges for the quarter ended 31 December 2025. The certificate was issued by its Registrar and Share Transfer Agent, MUFG Intime India Pvt. Ltd. (formerly Link Intime), confirming that all share dematerialisation requests received from depository participants during the quarter were duly processed and reflected in the company's register of members. The filing also notes that no rematerialisation requests were received during the quarter. This is a standard quarterly regulatory submission mandated under SEBI's Depositories Regulations.
This is a routine compliance filing with no material impact on the company's financials, operations, or stock price. It simply confirms that share transfer and dematerialisation activities are being handled in line with SEBI requirements.